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Abstract
Using random PCR in combination with next-generation sequencing, a novel parvovirus was detected in the brain of
a young harbor seal (Phoca vitulina) with chronic non-suppurative meningo-encephalitis that was rehabilitated at the
Seal Rehabilitation and Research Centre (SRRC) in the Netherlands. In addition, two novel viruses belonging to the
family Anelloviridae were detected in the lungs of this animal. Phylogenetic analysis of the coding sequence of the
novel parvovirus, tentatively called Seal parvovirus, indicated that this virus belonged to the genus Erythrovirus, to
which human parvovirus B19 also belongs. Although no other seals with similar signs were rehabilitated in SRRC in
recent years, a prevalence study of tissues of seals from the same area collected in the period 2008-2012 indicated
that the Seal parvovirus has circulated in the harbor seal population at least since 2008. The presence of the Seal
parvovirus in the brain was confirmed by real-time PCR and in vitro replication. Using in situ hybridization, we
showed for the first time that a parvovirus of the genus Erythrovirus was present in the Virchow-Robin space and in
cerebral parenchyma adjacent to the meninges. These findings showed that a parvovirus of the genus Erythrovirus
can be involved in central nervous system infection and inflammation, as has also been suspected but not proven for
human parvovirus B19 infection.
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Introduction
Parvoviruses are small, non-enveloped viruses containing a
single-stranded DNA genome of approximately 5 kb [1]. The
family Parvoviridae includes the subfamily Parvovirinae,
members of which infect vertebrates, and the subfamily
Densovirinae, members of which infect invertebrates. Five
genera of the subfamily Parvovirinae have been recognized by
the International Committee on the Taxonomy of Viruses
(ICTV), Amdovirus, Bocavirus, Dependovirus, Erythrovirus and
Parvovirus [2]. In addition, two new genera (Bufavirus and
Partetravirus) have been proposed within this subfamily [3,4].
Dependent on host, immune status, and parvovirus species,
clinical manifestations of parvovirus infection may range from
subclinical infection to severe diseases, including abortion,
chronic immune complex disease, enteritis, hepatitis and
myocarditis [1].
The genus Erythrovirus consists of four species (Human
parvovirus B19 and those which have so far only been
identified in primates: Pig-tailed macaque parvovirus, Rhesus
macaque parvovirus and Simian parvovirus) and two tentative
members (Bovine parvovirus type 3 and Chipmunk parvovirus)
[2]. Human parvovirus B19 is the best studied member of this
genus. This virus was identified as the cause of fifth disease, a
rash that occurs mainly in young children (for review see [5,6]:).
In addition, human parvovirus B19 has been associated with
severe hematological disorders, hydrops fetalis upon infection
during pregnancy and it was detected in cerebrospinal fluid
(CSF) and serum from patients with meningo-encephalitis
[5,7–9]. However, the exact pathogenesis of human parvovirus
B19 has not been fully elucidated [5]. In macaques,
erythroviruses were identified in animals with anemia [10,11],
while Bovine parvovirus type 3 and Chipmunk parvovirus were
identified in apparently healthy animals [12,13]. Upon
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experimental inoculation of cynomolgus macaques with Simian
parvovirus, macaques developed mild clinical signs including
transient cessation of erythropoiesis confirming the role of this
virus in the observed anemia [14].
In the present study, we described the identification, partial
characterization, and prevalence of a newly discovered
parvovirus, tentatively classified within the genus Erythrovirus
and called Seal parvovirus, that we detected in various organs,
including the brain, of a harbor seal with chronic brain disease.
Results
Macroscopic and microscopic observations
External examination of seal 12-410 at necropsy revealed
numerous ulcerated raised skin lesions varying in size from
5mm to several centimetres in diameter, mainly located at the
ventral side of the body and on the right front flipper. Internal
examination showed multiple firm dark red foci in the lungs. No
further gross abnormalities were observed in the brain or other
organs (Figure 1A). On MRI images of the brain, subdural
areas with a hypointense signal were found on all sequence
images, compatible with gas formation due to decomposition.
Upon histological examination, multifocally in the cerebrum,
cerebellum, brainstem, choroid plexus and meninges a mild
chronic non-suppurative meningo-encephalitis was observed,
characterized by the presence of a mononuclear perivascular
infiltrate consisting predominantly of lymphocytes up to 5 cell
layers thick (Figure 1B, C, D). Inflammatory cells did not extend
into the brain parenchyma surrounding affected blood vessels.
The skin had multifocal chronic severe proliferative and
necrotizing dermatitis with eosinophilic intracytoplasmic
inclusion bodies predominantly in acanthocytes, which might
have been caused by infection with Seal poxvirus [15]. The
lungs showed multifocal to coalescing chronic moderate
pyogranulomatous and eosinophilic bronchopneumonia with
intralesional nematodes. Such parasitic bronchopneumonia
was commonly observed in young harbour seals in this
population [16,17]. In the liver, mild hepatitis was observed
characterized by the presence of multifocal aggregates of small
numbers of neutrophils and mononuclear cells in portal areas
and in distended sinusoids, infrequently associated with
hepatocyte necrosis (Figure 1E). Multifocally in the spleen and
to a lesser extent in the liver, extramedullary haematopoiesis
was present, characterized by the presence of precursors of
the eyrthroid series and megakaryocytes (Figure 1F). No
histological abnormalities were detected in remaining organs.
Discovery of a novel parvovirus and two novel
anelloviruses
No herpesvirus and morbillivirus were detected by specific
PCR and isolated nucleic acids were further processed for
random PCR in combination with next-generation sequencing.
More than 70,000 reads were analyzed from the lungs and
brain of seal 12-410. Using BLAST analysis comparing these
sequences, 81 sequences were detected that showed the
closest similarity with Chipmunk parvovirus in the lung and
brain and 20 sequences were detected that showed the closest
similarity with Seal anellovirus TFFN/USA/2006 in the lung
[12,18]. The coding sequence of a novel parvovirus, tentatively
called Seal parvovirus, was obtained by Sanger sequencing
(Genbank accession number KF373759) in which three major
open reading frames were identified. The first ORF encoded
the putative non-structural (NS) protein (nt 319 to 2325), the
second ORF encoded the structural protein VP1 (nt 2347 to
4878), and the third ORF (nt 3175 to 4878), identified within the
VP1 gene, coded for the structural protein VP2 (Figure 2A).
Phylogenetic analysis of the deduced complete amino acid
sequence of the VP2 and NS1 protein revealed that this novel
parvovirus most likely belonged to the genus Erythrovirus
(Figure 2B + Figure S1). Analysis of the pairwise nucleotide
and deduced amino acid sequence identities between the NS1
and VP2 gene of the novel Seal parvovirus and various other
viruses of the subfamily Parvovirinae revealed that the VP2
gene had the highest identity with the Chipmunk parvovirus
Figure 1.  Evaluation of the presence of lesions by MRI and
histology.  A.Transverse T2-weighted MR image of the brain
of seal 12-410. No gross abnormalities were detected in the
brain parenchyma (the subdural hypointense areas are
compatible with air due to post-mortem preparation). B, C, D.
Perivascular cuffing with inflammatory cells distending the
Virchow-Robin space in the brain parenchyma (B, C) and in the
meninges (D). The infiltrates consisted mainly of mononuclear
cells. E. Infiltrates of neutrophils and mononuclear cells in the
liver parenchyma. F. Megakaryocytes and rubricytes in the
spleen associated with extramedullary hematopoiesis. H&E
stained slides, original magnification B, C, D: 200x; E, F: 400x.
doi: 10.1371/journal.pone.0079259.g001
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(only 39% on the deduced amino acid level), while the NS1
gene had the highest identity with the Pigtailed macaque
parvovirus (only 27% on the deduced amino acid level) (Table
S1 and S2).
In addition to the newly discovered Seal parvovirus, two
novel anelloviruses were detected and the complete
sequences of these viruses, tentatively called Seal
anelloviruses 2 and 3 (Genbank accessions KF373760 and
KF373758), were also obtained. Three major ORFs and a
TATA-box were identified in both anelloviruses, with a similar
genome organization as the anellovirus detected in seals
previously [18] (Figure 3A, B). A phylogenetic tree based on
the deduced amino acid sequence of the ORF1 sequences of
Seal anelloviruses 2 and 3 revealed that both viruses were
closely related to Seal anellovirus TFFN/USA/2006
(unclassified anellovirus) displaying respectively only 58% and
52% identity on the nucleotide level in ORF1 (Figure 3C).
Genera in the family Anelloviridae are defined as having >56%
divergence in the nucleotide sequence of ORF1 [19], indicating
that Seal anelloviruses 2 and 3 belonged to the same
anellovirus genus as Seal anellovirus TFFN/USA/2006.
Seal parvovirus detection by real-time PCR, ISH and in
vitro replication
In all tissues collected from seal 12-410, Seal parvovirus
DNA was detected by real-time PCR with Ct-values ranging
from 19 (spleen and lung) to 28 (brain stem) (Table 1). In
addition, Seal parvovirus DNA was detected in serum of this
seal collected shortly after arrival at the SRRC and in serum
collected at the moment of euthanasia (37 days after collection
of the original sample) (Table 1). No Seal parvovirus DNA was
detected by real-time PCR in the brain of another seal without
neurological signs, that died at about the same time. The
presence of Seal parvovirus DNA in the spleen and cerebrum
and cerebellum was confirmed by ISH. Multifocally, Seal
parvovirus DNA-probe signal was detected in the red pulp of
the spleen (Figure 4A, E, I), in blood vessels in the brain
parenchyma (Figure 4B, F, J), in the Virchow-Robin spaces of
the cerebrum (Figure 4C, G, K) and in the brain parenchyma
adjacent to the choroid plexus (Figure 4D, H, L). No clear
signal could be detected in the lungs and liver of seal 12-410,
in tissues of the same seal incubated with the negative control
probe and in tissues of the negative control seal (data not
shown).
The presence of infectious Seal parvovirus in the brain of
seal 12-410 was confirmed by in vitro culture using seal bone
marrow cells. The number of cultured cells increased and
erythropoiesis was induced in the presence of cEPO, which
was not the case in the absence of cEPO (Figure 5A, data not
shown). Following inoculation of bone marrow cells with lung
tissue homogenate, cells died rapidly, most likely due to the
presence of toxic components (data not shown). No increased
cell death was observed when brain tissue homogenate was
added (Figure 5A). Ct-values of cells inoculated with 40μl/ml
brain tissue and cEPO decreased from 33 at t=0 to 26 at t=7
and t=10, suggesting active virus replication (Figure 5B). No
Seal parvovirus DNA was detected in cells incubated with
transport medium only, with the same homogenate without
Figure 2.  Genome organization and phylogenetic analysis
of Seal parvovirus.  A. Genome organization of Seal
parvovirus. Indicated were the location of the major ORFs
(grey) and the location of the start- and stopcodons on the
nucleotide level counted from the 5’ end of the partial seal
parvovirus genome. B. Phylogenetic neighbor-joining tree with
p-distance and 1,000 bootstrap replicates of the deduced
amino acid sequences of the VP2 genes of various viruses of
the subfamily Parvovirinae. Genbank accession numbers:
Canine parvovirus 2a: JQ996152, Porcine parvovirus Tai’an:
FJ853421, Mouse parvovirus 2: NC_008186, Fox parvovirus:
KC692368, AMD (Aleutian Mink disease) parvovirus:
GU183264, Gray fox amdovirus: JN202450, Bufavirus-2 BF 39:
JX027297, Human parvovirus 4: AY622943, Swine parvovirus
H-1: AB076669, Bovine parvovirus 3: AF406967.
Seal parvovirus: KF373759, Chipmunk parvovirus: GQ200736,
Pig tailed macaque parvovirus: AF221123, Rhesus macaque
parvovirus: AF221122, Simian parvovirus: U26342, Human
parvovirus B19: NC_000883, Muscovy duck parvovirus:
NC_006147, Adeno-associated virus-2: NC_001401, Porcine
bocavirus 5: JN831651, Canine minute virus SH1: FJ899734,
Human bocavirus 3: HM132056.
doi: 10.1371/journal.pone.0079259.g002
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Figure 3.  Genome organization and phylogenetic analysis
of Seal anelloviruses 2 and 3.  A, B Genome organization of
the two novel anelloviruses, Seal anellovirus 2 (A) and Seal
anellovirus 3 (B). The location of the three main ORFs was
indicated (black line). C. Phylogenetic neighbor-joining tree
with p-distance and 1,000 bootstrap replicates of the deduced
amino acid sequences of the ORF1 genes of representative
viruses of the family Anelloviridae. Genbank accession
numbers: HsTTMDV1 (Homo sapiens torque teno midi virus 1):
NC_009225, HsTTMDV2 (Homo sapiens torque teno midi virus
2): NC_014093, HsTTMV1 (Homo sapiens torque teno mini
virus 1): NC_014097, HsTTMV2 (Homo sapiens torque teno
mini virus 2): NC_014086, PtTTV14 (Pan troglodytes torque
teno virus 14): NC_014077, HsTTV1 (Homo sapiens torque
teno virus 1): NC_007013, HSTTV10 (Homo sapiens torque
teno virus 10): GU797360, CfTTV10 (Canis familiaris torque
teno virus 10): NC_014071, TbTTV14 (Tupaia belangeri
chinensis torque teno virus 14): AB057358, SsTTV1 (Sus
sucrofa torque teno virus 1): AY823990, SeAV2 (Seal
anellovirus 2): KF373760 , SeAV3 (Seal anellovirus 3):
KF373758, SeAv TFFN (Seal anellovirus TFFN/USA/2006):
NC_015212, ZcAV (Zalophus californianus torque tenovirus):
FJ459582, FcTTV4 (Felis catus torque teno virus 4):
AB076003, PRA4 (Felis catus anellovirus PRA 4): EF538878,
PRA1 (Felis catus anellovirus PRA1): EF538877.
doi: 10.1371/journal.pone.0079259.g003
cEPO, or in cells incubated with 4μl/ml control brain tissue
homogenate with cEPO.
Prevalence of Seal parvovirus in harbor seals of the
Dutch coastal waters
To determine whether Seal parvovirus was present in the
harbor seal population in the Dutch coastal waters in recent
years, samples of spleens, brains and lungs of 94 additional
harbor seals on which a necropsy was performed at the SRRC
from 2008-2012 were collected and tested for the presence of
Seal parvovirus DNA by real-time PCR (Table 2). Seal
parvovirus DNA was detected in several tissues of two harbor
seals in addition to seal 12-410, one in 2008 and one in 2012
(Tables 1 and 2). In tissues of both of these additional seals,
Phocine herpesvirus 1 DNA was detected by PCR. In the seal
that had died in 2012, Seal parvovirus DNA was also detected
in the brain, although with a higher Ct-value than in seal 12-410
(Table 1).
Discussion
Various outbreaks of disease in marine mammals have been
the subject of virus discovery activities in the past decades.
Although influenza A viruses, morbilliviruses and a herpesvirus
were identified as major pathogens of harbor seals [20–22],
information about the presence of other viruses and their
pathogenicity is still limited. Recently, a novel anellovirus,
picornavirus and herpesviruses were detected during
outbreaks of disease [18,23,24]. Although parvoviruses are
known to be a major cause of disease of several terrestrial
carnivore species [25], they have not yet been detected in
Table 1. Summary of tissue distribution of Seal parvovirus
DNA in three positive seals.
Year 2008 2012 (12-410) 2012
Clinical signs Unknown   
Hemiparesis,
unconsiousness Pneumonia
Tissues tested for
Seal parvovirus
DNA by real-time
PCR*
Cerebrum - + (24) + (31)
 Cerebellum n.a. + (22) n.a.
 Brain stem n.a. + (28) n.a.
 Lung + (26) + (21) + (37)
 Spleen + (35) + (19) + (22)
 Kidney n.a. + (21) n.a.
 Liver n.a. + (23) + (37)
 Serum n.a. + (27-32)# n.a.
Detection of Phocine
herpesvirus 1 DNA + - +
* Ct-values are indicated in brackets
n.a.: not available
# Range of Ct-values of Seal parvovirus DNA detected in serum that was collected
at various timepoints from admission of the seal to the SRRC until euthanasia.
doi: 10.1371/journal.pone.0079259.t001
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harbor seals. In the present study, we described the detection
and partial characterization of a novel parvovirus, tentatively
called Seal parvovirus, in the brain of a harbor seal with severe
chronic neurological signs. In addition to this parvovirus, we
also discovered two novel anelloviruses (Seal anellovirus 2 and
3) in the lungs of the same seal. Since anelloviruses are
ubiquitous and their causative role in neurological disease was
not considered likely [19,26], we primarily focused on the
potential role of Seal parvovirus in the brain disease in the
present case.
The observed progressive clinical signs in seal 12-410
indicated CNS disease, which was confirmed by the presence
of a chronic meningo-encephalitis observed by histological
examination. We excluded the presence of several other
causes of brain disease by MRI (e.g. tumor or trauma) and by
PCR for morbilliviruses and herpesviruses, both important
infectious causes of encephalitis in harbor seals [27,28]. The
non-suppurative character of the meningo-encephalitis did not
fit with most bacterial causes. In addition, by random PCR in
combination with deep sequencing no bacterial sequences
known to be associated with meningo-encephalitis were
detected. Seal parvovirus DNA was detected retrospectively in
the serum of this animal already upon admission to the SRRC,
confirming the presence of an infection with this virus
Figure 5.  Replication of Seal parvovirus in vitro.  Bone
marrow cells of seal were incubated with (open symbols) or
without (closed symbols) canine erythropoietin and inoculated
with either PBS (diamond) or 2µl (circles) or 20µl (squares) of
brain tissue homogenate from the parvovirus positive seal. At
various time points after inoculations, samples were collected
for counting of live cells by FACSanalysis (A) or real time-PCR
using primers and probe specific for the Seal parvovirus (B).
The detection limit of the assay was indicated with ND (not
detectable).
doi: 10.1371/journal.pone.0079259.g005
Figure 4.  Detection of Seal parvovirus DNA by ISH.  Pictures of H&E stained tissues of seal 12-410 of the spleen (A), the
parenchyma of the cerebrum with a blood vessel (B), the Virchow-Robin space of the cerebellum (C) and the parenchyma of the
cerebellum adjacent to the meninges (D). Red dots that indicate the presence of Seal parvovirus DNA were detected in the red pulp
of the spleen (E, I), blood vessels in the brain parenchyma of the cerebrum (F, J), the Virchow-Robin space (G, K) and the brain
parenchyma adjacent to the meninges of the cerebellum (H, L). A, B, C, D, E, F, G, K: original magnification 200x. I, J, K, L: original
magnification 1000x.
doi: 10.1371/journal.pone.0079259.g004
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concurrent with the observed left-sided hemiparesis upon
admission. Since the presence of the newly identified Seal
parvovirus was also detected in the brain of this animal by real-
time PCR and in-situ hybridisation, it is likely that the
parvovirus infection played a role in the development of the
neurological disease of this animal. However, Koch’s
postulates would have to be fulfilled to formally prove the role
of this virus in the disease.
Human parvovirus B19, a phylogenetically closely related
virus, has been associated with meningo-encephalitis in
humans, mainly with underlying disease [7,8]. In all these
human cases Parvovirus B19 DNA infection of the brain was
diagnosed by PCR in CSF or serum [7,29], indicating that this
is the first report that indeed shows that parvoviruses of the
genus Erythrovirus can be present in the Virchow-Robin space
and in the brain parenchyma adjacent to the meninges in
mammals. Since we used a probe targeting DNA and not RNA
to be able to detect a signal and we did not detect Parovirus
DNA in the nuclei of cells, additional studies using RNA probes
are of interest to elucidate whether viral replication might occur
in dividing cells of the brain. In vitro experiments suggested
that infectious viral particles were present in the brain tissue of
seal 12-410. The observed decrease of the Ct-value from 33 to
26 suggests an approximately 150-fold increase in the amount
of viral DNA based on calibration experiments (data not
shown), which is similar to previous in vitro infection
experiments with human parvovirus B19 and human bone
marrow cells [30]. However, we were not able to repeat this
experiment with fresh bone marrow cells from another seal that
died at the SRRC, indicating that the in vitro infection system is
rather inefficient. In addition, no cytopathic effect was observed
which might be related to the relatively low number of infected
cells in vitro. The absence of visible cytopathic effect does not
exclude that this virus is indeed pathogenic in vivo, since many
viruses do not cause visible cytopathic effect but are still
pathogenic [31,32]. In addition to the brain, Seal parvovirus
DNA was detected in various other tissues, including the lung,
the liver and the spleen. While Parvovirus DNA could be
detected in the spleen by ISH, no strong positive signal was
detected in the liver and lungs. The relatively long storage of
these tissues in formalin might have impaired the signal. Of
interest, extramedullary hematopoiesis was observed in the
spleen of this seal, which could have been caused by the
chronic infection with Seal parvovirus as was demonstrated for
other members of the genus erythrovirus [6,10,11]. However,
Table 2. Summary of animals tested for Seal parvovirus
DNA.
Year 2008 2009 2010 2011 2012 Total
Pup 0/3* 0/1 0/0 0/1 0/2 0/6
Juvenile 0/12 0/13 0/16 0/12 2/14 2/67
(Sub)adult 0/4 0/1 0/2 0/5 0/4 0/26
Unknown 1/1 0/0 0/2 0/2 0/0 1/5
Total number 1/20 0/15 0/20 0/20 2/20 3/95
* Number of Seal parvovirus DNA positive seals/ number of seals tested
doi: 10.1371/journal.pone.0079259.t002
extramedullary haematopoiesis was also observed in young
pinnipeds without clinical signs [33].
No other seals were admitted to the SRRC in the past few
years with similar clinical signs, suggesting that this case is
probably a relatively unique event possibly associated with the
presence of unknown host factors, similar to parvovirus-B19-
associated meningo-encephalitis in humans [7,8]. Parvovirus
DNA was detected in two other seals, one in 2008 and one in
2012, suggesting that this virus must have circulated among
harbor seals of the Dutch coastal waters at least as early as
2008. However, both seals were co-infected with Phocine
herpesvirus-1. Of interest, co-infection of humans with various
pathogens and parvovirus B19 has been associated with
progression to more severe disease previously [34–36]. The
role of Seal parvovirus in the disease of the two other animals
remained uncertain and should be the focus of additional
studies.
In conclusion, we have described a seal with chronic non-
suppurative meningo-encephalitis associated with infection with
a novel parvovirus, tentatively named Seal parvovirus. These
findings suggest that parvoviruses of the genus Erythrovirus
can be involved in CNS inflammation, as has been suggested
for Human parvovirus B19 [7,8]. The exact pathogenesis of this
viral infection and the possible role of various host factors and
co-infection with other pathogens should be the focus of future
research.
Materials and Methods
Ethics statement
All samples of seals used in the present study were provided
by the SRRC, and the SRRC provided permission to the
Department of Viroscience, Erasmus Medical Centre to use the
samples for the present study. Admission and rehabilitation of
wild seals at the SRRC and collection of wild dead seals for
diagnostic purposes by the SRRC is permitted by the
government of the Netherlands (application number FF/
75/2012/015). In the present study, only samples were used
that were collected from dead seals. These samples were
collected from seals that were either found dead in the wild by
the SRRC, died at the SRRC despite intensive care or were
euthanized at the SRRC due to the presence of severe clinical
signs in the absence of any indication of future recovery. In
case of euthanasia, this was performed with T-61 (0.3ml/kg)
after sedation as described previously [37]. No seals were
euthanized for research purposes.
Case description
A young male harbor seal (Phoca vitulina; approximately one
year of age; rehabilitation number 12-410) stranded on the
Dutch coast and was admitted to the Seal Rehabilitation and
Research Centre (SRRC) in 2012. Upon arrival at the centre,
the seal displayed left-sided hemiparesis. Despite treatment
with antibiotics and anti-inflammatory medication for several
weeks, the seal developed severe central nervous system
(CNS) sings including episodes of unconsciousness. Since no
recovery was observed, the seal was euthanized as described
previously [37].
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Sample collection and evaluation of the presence of
(histo)pathologic changes
Following euthanasia, the carcass was stored at -20°C for a
few weeks. Subsequently, it was subjected to necropsy upon
thawing and samples of brain, lungs, liver, spleen, kidney and
urinary bladder were collected and stored at either -70°C or
fixed in 10% neutral buffered formalin. In addition, the complete
head was stored at -20°C for several weeks until further
analysis by magnetic resonance imaging (MRI). A MRI study of
the cranium was performed using a 0.2 Tesla open magnet
(Magnetom Open Viva, Siemens AG, Munich, Germany). T1-
weighted spin echo, T2 and proton density weighted turbo spin
echo, Fluid Attenuated Inversion Recovery (FLAIR), Short Tau
Inversion Recovery (STIR) and T1-weighted 3D gradient echo
sequences were acquired in the transverse plane. Dual Echo
Steady State (DESS) images were acquired in the dorsal
plane. Subsequently, multiple samples of the brain stem,
cerebellum and cerebrum were collected and stored at -70°C
or fixed in 10% neutral-buffered formalin. After fixation,
samples collected from various tissues were embedded in
paraffin and 4- μm-thick tissue sections were stained with
hematoxylin and eosin and evaluated for the presence of
histological lesions.
Processing of samples for specific PCR and random
PCR in combination with next-generation sequencing
Tissues collected of seal 12-410 were tested for the
presence of herpesvirus (lung, brain) and morbillivirus (brain)
using a pan-herpes PCR and pan-morbillivirus PCR,
respectively, as described previously [38,39]. In addition,
samples of lungs and brain were processed for sequence
independent RNA and DNA virus screening as described
previously [40–42]. In brief, tissues were homogenized using a
Fastprep-24 Tissue Homogenizer (MP Biomedicals) in Hank's
balanced salt solution containing 0.5% lactalbumin, 10%
glycerol, 200 U/ml penicillin, 200 μg/ml streptomycin, 100U/ml
polymyxin B sulfate, 250 μg/ml gentamycin, and 50 U/ml
nystatin (ICN Pharmaceuticals) (transport medium) and
centrifuged briefly. Supernatants from tissue homogenates
were filtered and treated with nucleases to decrease host DNA
and RNA, after which RNA and DNA were extracted. After first
and second strand synthesis, random amplification was
performed and amplicons were processed for next-generation
sequencing with a 454 GS Junior instrument (Roche). Reads
were trimmed and assembled with de novo assembly using
CLC Genomics Workbench 5 (CLC Bio), and analyzed by
nucleotide and translated nucleotide BLAST searches.
Sequences were classified based on the taxonomic origin of
the best-hit sequence with MEGAN 4.70.4 [43], using E-value
cut-offs of 0.001 and 10-10 for BLASTn and BLASTx searches,
respectively. Obtained reads were deposited at the European
Nucleotide Archive under archive number ERP003897.
Genome sequencing and phylogenetic analysis
Using specific primers based on obtained 454-sequences,
partially overlapping PCR amplicons spanning the near full-
length genome of the novel seal parvovirus were obtained. To
obtain 5’ and 3’ distal parts of the coding sequences of the
major ORFs, parvovirus DNA was circularized using T4 DNA
ligase and ligated 5’ and 3’ ends were amplified by specific
primers. Amplicons were cloned into pCR4 Topo vector
(Invitrogen) and sequences of at least two clones in two
directions were obtained. Primer sequences are available upon
request. The complete genome of two novel anelloviruses was
obtained by rolling circle amplification using the Illustra
Templiphi 100 amplification kit (GE Healthcare) with specific
primers according to the recommendations of the
manufacturer. PCR amplicons were separated by gel
electrophoresis and bands of the right size were processed by
sequence independent DNA amplification in combination with
next-generation sequencing as described above. Obtained
reads were analysed with the CLC Genomics Workbench 5
software and consensus sequences of the two novel
anelloviruses were obtained. Phylogenetic analysis was
performed by creation of multiple alignments using the
ClustalW method in MEGA5 [44] based on the deduced amino
acid sequences of the VP2 genes of the detected parvovirus
and other representative parvoviruses and ORF1 of the novel
anelloviruses and other anelloviruses [44]. Neighbour-joining
phylogenetic trees were build with the p-distance model, 1000
bootstrap replicates, and otherwise default parameters in
MEGA5 [44].
Detection of Seal parvovirus in the tissue of seal 12-410
by real-time PCR and in situ hybridization
Using Primer Express software (version 3.0, Applied
Biosystems) a real-time PCR was developed targeting a small
fragment of the VP1 gene of the novel parvovirus, using
forward primer 5’-CCTCGCAGGCATTTTCATG-3’, reverse
primer 5’-TGCAAGAGCATCCACGGATA-3’ and probe 5’-FAM-
AAACACAATCCTGACCGAGA-BHQ-3’. Amplification and
detection of the Seal parvovirus DNA in nucleic acids of
collected tissues was performed using a 7500 Real Time PCR
system (Applied Biosystems) and Taqman Universal Mastermix
(Applied Biosystems). All real-time PCRs were performed in
duplo.
In addition to the real-time PCR, tissue sections of the
cerebrum, cerebellum, lungs, spleen and liver of seal 12-410
were examined for the presence of the Seal parvovirus DNA by
in situ hybridization (ISH) using a specific probe targeting the
VP1 gene of Seal parvovirus and the RNAscope 2.0 kit
(Advanced Cell Diagnostics) essentially according to the
instructions of the manufacturer. In brief, 5μm-thick tissue
sections were deparaffinized, treated with alkylphenol
ethoxylate (APE), boiled for 10 minutes and pre-treated with
buffers provided by the manufacturer. Subsequently, the
specific probe was hybridized for two hours at 40°C and the
signal was amplified by six amplification steps and visualised
with FastRed. Sections were counterstained with hematoxylin.
In addition, formalin pigment in tissue sections of lungs and
spleen was removed by pre-treatment of sections with APE.
The quality of the tissues was confirmed using the Ubiquitin C
control and slides processed with a DapB probe provided by
the manufacturer. In addition, brain tissue sections of an age-
matched control seal without neurological signs and
undetectable Seal parvovirus DNA by real-time PCR were used
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as controls for the presence of a Seal parvovirus specific
signal.
Replication of newly discovered Seal parvovirus in
vitro
The presence of infectious virus in brain and lung tissue of
seal 12-410 was evaluated by inoculation of suspension
cultures of fresh harbor seal bone marrow cells with brain and
lung tissue homogenate essentially as described previously for
human parvovirus B19 [30]. In brief, femur bones of a seal that
had died at the SRRC from an apparently non-infectious cause,
were collected, cleaned by storage in 70% ethanol for 5
minutes and rinsed twice with phosphate buffered saline (PBS).
Subsequently, bones were stored in cold RPMI 1640 medium
(Cambrex, East Rutherford, NJ) supplemented with 20% fetal
bovine serum, 500IU/ml penicillin and 500μg/ml streptomycin
(Culture medium) for three hours until bone marrow cells were
collected by flushing out bone marrow with culture medium.
Obtained cells were centrifuged, resuspended in PBS, and
mononuclear cells were isolated by density gradient
centrifugation using Lymphoprep solution (Axis-Shield, PoC
AS, Oslo, Norway). Isolated cells were washed with PBS
supplemented with 2.5mM EDTA, resuspended in RPMI 1640
medium supplemented with 500IU/ml penicillin and 500μg/ml
streptomycin, and live cells were counted by trypan blue
exclusion.
Subsequently, 10x106 cells/ml were inoculated with either 4
or 40 μl brain or lung tissue homogenate or transport medium
(negative control). After storage at 4°C for 2 hours, culture
medium with or without 40ng/ml recombinant canine
erythropoietin (cEPO; R&D Systems, Minneapolis, USA) was
added to a final concentration of 2x106 cells/ml and cells were
stored at 37ºC/5% CO2. At 0, 1, 3, 5, 7 and 10 days post
inoculation, samples of the suspension cultures were collected
for determination of the quantity of Seal parvovirus DNA using
real-time PCR and at 1, 3, 5 and 7 days post inoculation for
determination of the number of cells. Cell numbers were
determined by acquiring a fixed volume of cells with a
FACSCantoII (BD, Alphen a/d Rijn, the Netherlands) and
analysed using FACS Diva Software (BD).
Prevalence study
Samples of spleens, brains and lungs of 94 additional harbor
seals, on which a necropsy was performed at the SRRC from
2008-2012 were collected and tested for the presence of Seal
parvovirus DNA by real-time PCR (Table 2). Tested samples
were collected from wild (n=16) and rehabilitated (n=71) harbor
seals or were of unknown origin (n=7) and seals were divided
into age groups as described previously [45]. No other seals
were rehabilitated in the past few years with signs similar to
those of seal 12-410, and severe (parasitic) bronchopneumonia
was the main suspected cause of death (68%) of the seals that
were screened for the presence of Seal parvovirus DNA.
Supporting Information
Figure S1.  Phylogenetic analysis of the NS1 protein of
Seal parvovirus. Phylogenetic neighbor-joining tree with p-
distance and 1,000 bootstrap replicates of the deduced amino
acid sequences of NS1 genes of various viruses of the
subfamiliy Parvovirinae. Significant bootstrap values are
shown. Genbank accessions: Canine parvovirus CPV-N:
M19296, Mouse parvovirus UT: AB234204, Porcine parvovirus
Tai’an: FJ853421, Fox parvovirus: KC692368, Bufavirus-2 BF
39: JX027297, Gray fox amdovirus: JN202450, AMD (Aleutian
Mink disease) parvovirus: GU183264, Human parvovirus 4:
AY622943, Swine parvovirus H-1: AB076669, Adeno-
associated virus-2: NC_001401, Duck parvovirus: NC_006147,
Seal parvovirus: KF373759, Bovine parvovirus 3: AF406967,
Chipmunk parvovirus: GQ200736, Human parvovirus B19:
NC_000883, Pig tailed macaque parvovirus: AF221123, Simian
parvovirus: U26342, Rhesus macaque parvovirus: AF221122,
Porcine bocavirus 5: JN831651, Canine minute virus SH1:
FJ899734, Human bocavirus 3: HM132056.
(TIF)
Table S1.  Nucleotide (NT) and deduced amino acid (AA)
sequence identities (%) between the VP2 gene of Seal
parvovirus and selected other parvoviruses of the genera
Erythrovirus, Partetravirus, Adeno-associated virus and
Parvovirus.
(DOC)
Table S2.  Nucleotide (NT) and deduced amino acid (AA)
sequence identities (%) between the NS1 gene of Seal
parvovirus and selected other parvoviruses of the genera
Erythrovirus, Partetravirus, Adeno-associated virus and
Parvovirus.
(DOC)
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